Arcus Biosciences Stock (NYSE: RCUS) stock price, news, charts, stock research, profile.
Open | $14.770 |
Close | $15.500 |
Volume / Avg. | 582.461K / 827.683K |
Day Range | 14.570 - 15.620 |
52 Wk Range | 12.950 - 25.470 |
Market Cap | $1.408B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 42 |
Short Interest | 13.63% |
Days to Cover | 11.43 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Arcus Biosciences (NYSE: RCUS) through any online brokerage.
Other companies in Arcus Biosciences’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Prothena Corp (NASDAQ:PRTA), Day One Biopharmaceutical (NASDAQ:DAWN) and Xencor (NASDAQ:XNCR).
The latest price target for Arcus Biosciences (NYSE: RCUS) was reported by Truist Securities on Monday, March 25, 2024. The analyst firm set a price target for 50.00 expecting RCUS to rise to within 12 months (a possible 222.58% upside). 19 analyst firms have reported ratings in the last year.
The stock price for Arcus Biosciences (NYSE: RCUS) is $15.5 last updated April 23, 2024 at 4:05 PM EDT.
There are no upcoming dividends for Arcus Biosciences.
Arcus Biosciences’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Arcus Biosciences.
Arcus Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.